Beam Therapeutics：估值仍具上涨空间 (NASDAQ:BEAM)
· seekingalpha.com
Beam Therapeutics (BEAM) 股票前景：基因编辑研发管线、持续至 2029 年的充足现金流以及保守的估值。
Max is an independent equity research analyst with a primary focus on biotechnology, healthcare, and technology companies. His investment approach is fundamenta...